Table 3. Analysis results for recurrence-free survival and overall survival.
| 5-year recurrence free survival | Log-rank | 5-year overall survival | Log-rank | |
| Characteristics | % | p | % | p |
| Sex | ||||
| Female | 42.3 | 0.705 | 58 | 0.615 |
| Male | 41.6 | 58.7 | ||
| Tumor type | ||||
| Primary | 47 | 0.663 | 53.6 | 0.313 |
| Secondary Tumor pathology | 40.4 | 62.6 | ||
| Carcinoma | 40.9 | 62.7 | ||
| Sarcoma | 47.4 | 0.756 | 54.3 | 0.341 |
| Grade | ||||
| 1 | 62.5 | 70 | ||
| 2 | 49.1 | 0.072 | 61.4 | 0.011 |
| 3 | 18.9 | 47.4 | ||
| Stage | ||||
| I | 83.3 | 83.3 | ||
| II | 36.1 | 58.1 | ||
| III | 42.1 | 0.138 | 46.7 | 0.169 |
| IV | 25.9 | 63.5 | ||
| Resection margin | ||||
| Positive | 0 | 0.386 | 72.9 | 0.303 |
| Negative | 47.6 | 56.7 | ||
| Rib resection | ||||
| Yes | 49.6 | <0.001 | 64 | 0.015 |
| No | 10 | 25.6 | ||
| Neoadjuvant treatment | ||||
| Yes | 51.5 | 0.627 | 74.4 | 0.160 |
| No | 39.1 | 51.8 | ||
| Adjuvant treatment | ||||
| Yes | 40.1 | 59.4 | ||
| No | 58.4 | 0.476 | 62.5 | 0.441 |